(19)
(11) EP 0 769 939 A1

(12)

(43) Date of publication:
02.05.1997 Bulletin 1997/18

(21) Application number: 95943503.0

(22) Date of filing: 07.07.1995
(51) International Patent Classification (IPC): 
A61K 45/ 00( . )
A61K 31/ 16( . )
A61K 31/ 215( . )
A61K 31/ 381( . )
A61K 31/ 4045( . )
A61P 37/ 00( . )
A61P 43/ 00( . )
A61K 31/ 00( . )
A61K 31/ 165( . )
A61K 31/ 38( . )
A61K 31/ 40( . )
A61K 31/ 66( . )
A61P 37/ 08( . )
(86) International application number:
PCT/EP1995/002693
(87) International publication number:
WO 1996/002240 (01.02.1996 Gazette 1996/06)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
SI

(30) Priority: 13.07.1994 GB 19940014157

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford, Middlesex TW8 9EP (GB)

(72) Inventors:
  • CHRISTIE, Gary
    Welwyn Hertfordshire AL6 9AR (GB)
  • WESTON, Beverley, Jane
    Betchworth Surrey RH3 7AJ (GB)

(74) Representative: West, Vivien, et al 
SmithKline Beecham plc Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) USE OF INHIBITORS OF HUMAN S-CD23